Surgical or Medical Treatment of Breast Cancer Metastasis: A Multicentre Observational Study
Status: Recruiting
Location: See location...
Study Type: Observational
SUMMARY
The liver represents the third most common site of breast cancer (BC) metastases behind the lymphatics and bone. The primary treatment for BCLM remains chemo-therapy and, more recently, targeted immunotherapy. The role of liver resection in BCLM remains controversial. The primary aim of the study is to compare the efficacy of liver resection vs. medical therapy alone in Breast Cancer Liver Metastasis (BCLM) patients.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:
• \> 18 years old
• BCLM
• BCLM and extra-hepatic disease
• Any treatment
• Ability to understand and sign the informed consent
Locations
Other Locations
Italy
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
RECRUITING
Rome
Contact Information
Primary
Amelia Mattia, MD
amelia.mattia01@icatt.it
+390453015
Time Frame
Start Date: 2018-04-01
Estimated Completion Date: 2028-12-31
Participants
Target number of participants: 720
Treatments
BCLM-surg
BCLM underwent liver resection
BCLM-med
BCLM underwent medical treatment alone
Related Therapeutic Areas
Sponsors
Leads: Fondazione Policlinico Universitario Agostino Gemelli IRCCS